Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production

Nature Biotechnology

Volumn 31, Issue 2, 2013, Pages 160-165

  Brynildsen, Mark P ^a,e   Winkler, Jonathan A ^a,b   Spina, Catherine S ^a,c,d   MacDonald, I Cody ^a   Collins, James J ^a,b,c,d  

^a Boston University   (United States)

^b BOSTON UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD UNIVERSITY   (United States)

^e Princeton University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-BACTERIAL ACTIVITY; ANTIBIOTIC ACTIVITY; E. COLI; ENSEMBLE APPROACHES; FLUX DISTRIBUTIONS; GLOBAL PUBLIC HEALTH; IN-SILICO; METABOLIC MODELS; METABOLIC NETWORK; NOVEL STRATEGIES; OXIDATIVE ATTACK; REACTIVE OXYGEN SPECIES;

BACTERIA; ESCHERICHIA COLI; OXIDANTS;

ANTIBIOTICS;

ANTIBIOTIC AGENT; REACTIVE OXYGEN METABOLITE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENOME; COMPUTER MODEL; DRUG POTENTIATION; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HUMANS; HYDROGEN PEROXIDE; MICROBIAL SENSITIVITY TESTS; OXIDANTS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES;

EID: 84873587763     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2458     Document Type: Article

References (36)

1. Arias, C.A. & Murray, B.E. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge. N. Engl. J. Med. 360, 439-443 (2009).
2. Foti, J.J., Devadoss, B., Winkler, J.A., Collins, J.J. & Walker, G.C. Oxidation of the guanine nucleotide pool underlies cell death by bactericidal antibiotics. Science 336, 315-319 (2012).
3. Kohanski, M.A., Dwyer, D.J., Hayete, B., Lawrence, C.A. & Collins, J.J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130, 797-810 (2007).
4. Kohanski, M.A., Dwyer, D.J., Wierzbowski, J., Cottarel, G. & Collins, J.J. Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 135, 679-690 (2008).
5. Carlioz, A. & Touati, D. Isolation of superoxide dismutase mutants in Escherichia coli: is superoxide dismutase necessary for aerobic life? EMBO J. 5, 623-630 (1986).
6. Loewen, P.C. Isolation of catalase-deficient Escherichia coli mutants and genetic mapping of katE, a locus that affects catalase activity. J. Bacteriol. 157, 622-626 (1984).
7. Dwyer, D.J., Kohanski, M.A., Hayete, B. & Collins, J.J. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol. Syst. Biol. 3, 91 (2007).
8. Hebrard, M., Viala, J.P., Meresse, S., Barras, F. & Aussel, L. Redundant hydrogen peroxide scavengers contribute to Salmonella virulence and oxidative stress resistance. J. Bacteriol. 191, 4605-4614 (2009).
9. Liu, C.I. et al. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science 319, 1391-1394 (2008).
10. Imlay, J.A. & Fridovich, I. Assay of metabolic superoxide production in Escherichia coli. J. Biol. Chem. 266, 6957-6965 (1991).
11. Korshunov, S. & Imlay, J.A. Two sources of endogenous hydrogen peroxide in Escherichia coli. Mol. Microbiol. 75, 1389-1401 (2010).
12. Massey, V. Activation of molecular oxygen by flavins and flavoproteins. J. Biol. Chem. 269, 22459-22462 (1994).
13. Messner, K.R. & Imlay, J.A. The identification of primary sites of superoxide and hydrogen peroxide formation in the aerobic respiratory chain and sulfite reductase complex of Escherichia coli. J. Biol. Chem. 274, 10119-10128 (1999).
14. Feist, A.M. & Palsson, B.O. The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli. Nat. Biotechnol. 26, 659-667 (2008).
15. Becker, S.A. & Palsson, B.O. Context-specific metabolic networks are consistent with experiments. PLoS Comput. Biol. 4, e1000082 (2008).
16. Covert, M.W., Knight, E.M., Reed, J.L., Herrgard, M.J. & Palsson, B.O. Integrating high-throughput and computational data elucidates bacterial networks. Nature 429, 92-96 (2004).
17. Feist, A.M. et al. A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol. Syst. Biol. 3, 121 (2007).
18. Messner, K.R. & Imlay, J.A. Mechanism of superoxide and hydrogen peroxide formation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase. J. Biol. Chem. 277, 42563-42571 (2002).
19. Edwards, J.S., Ibarra, R.U. & Palsson, B.O. In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data. Nat. Biotechnol. 19, 125-130 (2001).
20. Imlay, J.A. Pathways of oxidative damage. Annu. Rev. Microbiol. 57, 395-418 (2003).
21. Winter, J., Ilbert, M., Graf, P.C., Ozcelik, D. & Jakob, U. Bleach activates a redox-regulated chaperone by oxidative protein unfolding. Cell 135, 691-701 (2008).
22. Taber, H.W., Mueller, J.P., Miller, P.F. & Arrow, A.S. Bacterial uptake of aminoglycoside antibiotics. Microbiol. Rev. 51, 439-457 (1987).
23. Jensen, P.R. & Michelsen, O. Carbon and energy metabolism of atp mutants of Escherichia coli. J. Bacteriol. 174, 7635-7641 (1992).
24. Boshoff, H.I. et al. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J. Biol. Chem. 279, 40174-40184 (2004).
25. AbuOun, M. et al. Genome scale reconstruction of a Salmonella metabolic model: comparison of similarity and differences with a commensal Escherichia coli strain. J. Biol. Chem. 284, 29480-29488 (2009).
26. Becker, S.A. & Palsson, B.O. Genome-scale reconstruction of the metabolic network in Staphylococcus aureus N315: an initial draft to the two-dimensional annotation. BMC Microbiol. 5, 8 (2005).
27. Jamshidi, N. & Palsson, B.O. Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets. BMC Syst. Biol. 1, 26 (2007).
28. Schilling, C.H. & Palsson, B.O. Assessment of the metabolic capabilities of Haemophilus influenzae Rd through a genome-scale pathway analysis. J. Theor. Biol. 203, 249-283 (2000).
29. Henry, C.S. et al. High-throughput generation, optimization and analysis of genome-scale metabolic models. Nat. Biotechnol. 28, 977-982 (2010).
30. Baba, T. et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2, 2006.0008 (2006).
31. Belousov, V.V. et al. Genetically encoded fluorescent indicator for intracellular hydrogen peroxide. Nat. Methods 3, 281-286 (2006).
32. Malinouski, M., Zhou, Y., Belousov, V.V., Hatfield, D.L. & Gladyshev, V.N. Hydrogen peroxide probes directed to different cellular compartments. PLoS ONE 6, e14564 (2011).
33. Dukan, S. & Touati, D. Hypochlorous acid stress in Escherichia coli: resistance, DNA damage, and comparison with hydrogen peroxide stress. J. Bacteriol. 178, 6145-6150 (1996).
34. Yeh, P. & Kishony, R. Networks from drug-drug surfaces. Mol. Syst. Biol. 3, 85 (2007).
35. Hegreness, M., Shoresh, N., Damian, D., Hartl, D. & Kishony, R. Accelerated evolution of resistance in multidrug environments. Proc. Natl. Acad. Sci. USA 105, 13977-13981 (2008).
36. Becker, S.A. et al. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox. Nat. Protoc. 2, 727-738 (2007).